ID   DAPK2_HUMAN             Reviewed;         370 AA.
AC   Q9UIK4; O75892; Q24JS1;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   05-OCT-2010, entry version 97.
DE   RecName: Full=Death-associated protein kinase 2;
DE            Short=DAP kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=DAP-kinase-related protein 1;
DE            Short=DRP-1;
GN   Name=DAPK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF LYS-52.
RC   TISSUE=Skeletal muscle;
RX   MEDLINE=99303018; PubMed=10376525; DOI=10.1038/sj.onc.1202701;
RA   Kawai T., Nomura F., Hoshino K., Copeland N.G., Gilbert D.J.,
RA   Jenkins N.A., Akira S.;
RT   "Death-associated protein kinase 2 is a new calcium/calmodulin-
RT   dependent protein kinase that signals apoptosis through its catalytic
RT   activity.";
RL   Oncogene 18:3471-3480(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   HOMODIMERIZATION, AND MUTAGENESIS OF LYS-52.
RC   TISSUE=Kidney;
RX   MEDLINE=20094983; PubMed=10629061;
RX   DOI=10.1128/MCB.20.3.1044-1054.2000;
RA   Inbal B., Shani G., Cohen O., Kissil J.L., Kimchi A.;
RT   "Death-associated protein kinase-related protein 1, a novel
RT   serine/threonine kinase involved in apoptosis.";
RL   Mol. Cell. Biol. 20:1044-1054(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, HOMODIMERIZATION, MUTAGENESIS OF LYS-52; SER-299; SER-318;
RP   SER-320; SER-323 AND THR-329, AND PHOSPHORYLATION AT SER-318.
RX   MEDLINE=21153208; PubMed=11230133; DOI=10.1093/emboj/20.5.1099;
RA   Shani G., Henis-Korenblit S., Jona G., Gileadi O., Eisenstein M.,
RA   Ziv T., Admon A., Kimchi A.;
RT   "Autophosphorylation restrains the apoptotic activity of DRP-1 kinase
RT   by controlling dimerization and calmodulin binding.";
RL   EMBO J. 20:1099-1113(2001).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-60 AND TRP-271.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent serine/threonine kinase
CC       which acts as a positive regulator of apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Negatively regulated by autophosphorylation on
CC       Ser-318.
CC   -!- SUBUNIT: Homodimer. Homodimerization is required for apoptotic
CC       function and is inhibited by autophosphorylation at Ser-318.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-77154, EBI-77154;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in all tissue types
CC       examined. High levels in heart, lung and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. DAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB018001; BAA88063.1; -; mRNA.
DR   EMBL; AF052941; AAC35001.1; -; mRNA.
DR   EMBL; BC114506; AAI14507.1; -; mRNA.
DR   IPI; IPI00033388; -.
DR   RefSeq; NP_055141.2; -.
DR   UniGene; Hs.237886; -.
DR   PDB; 1WMK; X-ray; 3.60 A; A/B/C/D/E/F/G/H=11-330.
DR   PDB; 1WRZ; X-ray; 2.00 A; B=312-330.
DR   PDB; 1Z9X; X-ray; 3.93 A; A/B/C=11-330.
DR   PDB; 1ZWS; X-ray; 2.90 A; A/B/C/D/E/F/G/H=11-297.
DR   PDB; 2A27; X-ray; 3.00 A; A/B/C/D/E/F/G/H=11-330.
DR   PDB; 2A2A; X-ray; 1.47 A; A/B/C/D=11-330.
DR   PDB; 2CKE; X-ray; 2.80 A; A/B/C/D=11-330.
DR   PDBsum; 1WMK; -.
DR   PDBsum; 1WRZ; -.
DR   PDBsum; 1Z9X; -.
DR   PDBsum; 1ZWS; -.
DR   PDBsum; 2A27; -.
DR   PDBsum; 2A2A; -.
DR   PDBsum; 2CKE; -.
DR   ProteinModelPortal; Q9UIK4; -.
DR   IntAct; Q9UIK4; 3.
DR   STRING; Q9UIK4; -.
DR   PhosphoSite; Q9UIK4; -.
DR   PRIDE; Q9UIK4; -.
DR   Ensembl; ENST00000261891; ENSP00000261891; ENSG00000035664.
DR   Ensembl; ENST00000457488; ENSP00000408277; ENSG00000035664.
DR   GeneID; 23604; -.
DR   KEGG; hsa:23604; -.
DR   UCSC; uc002amr.1; human.
DR   CTD; 23604; -.
DR   GeneCards; GC15M064199; -.
DR   H-InvDB; HIX0019168; -.
DR   HGNC; HGNC:2675; DAPK2.
DR   PharmGKB; PA27143; -.
DR   eggNOG; prNOG05364; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG100551; -.
DR   InParanoid; Q9UIK4; -.
DR   OMA; HPWIMPV; -.
DR   OrthoDB; EOG9ZW7WM; -.
DR   PhylomeDB; Q9UIK4; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_578; Apoptosis.
DR   NextBio; 46296; -.
DR   ArrayExpress; Q9UIK4; -.
DR   Bgee; Q9UIK4; -.
DR   CleanEx; HS_DAPK2; -.
DR   Genevestigator; Q9UIK4; -.
DR   GermOnline; ENSG00000035664; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0006917; P:induction of apoptosis; IMP:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR020676; Death-assoc_prot_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020675; Myosin_light_chain_kin-rel.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22964:SF1; Death-assoc_prot_kinase; 1.
DR   PANTHER; PTHR22964; Myosin_light_chain_kin-rel; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Calmodulin-binding;
KW   Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    370       Death-associated protein kinase 2.
FT                                /FTId=PRO_0000085912.
FT   DOMAIN       23    285       Protein kinase.
FT   NP_BIND      29     37       ATP (By similarity).
FT   REGION      277    344       Calmodulin-binding.
FT   ACT_SITE    149    149       Proton acceptor (By similarity).
FT   BINDING      52     52       ATP.
FT   MOD_RES     299    299       Phosphoserine (By similarity).
FT   MOD_RES     318    318       Phosphoserine; by autocatalysis.
FT   MOD_RES     349    349       Phosphoserine.
FT   VARIANT      60     60       R -> W (in dbSNP:rs56047843).
FT                                /FTId=VAR_040436.
FT   VARIANT     271    271       R -> W (in dbSNP:rs34270163).
FT                                /FTId=VAR_040437.
FT   MUTAGEN      52     52       K->A: Loss of activity, apoptotic
FT                                function and of autophosphorylation.
FT   MUTAGEN     299    330       Missing: Loss of ca(2+)-calmodulin
FT                                binding, increase in activity, loss of
FT                                autophosphorylation.
FT   MUTAGEN     299    299       S->A: No effect on Ca(2+)-calmodulin
FT                                independent phosphorylation or apoptotic
FT                                activity.
FT   MUTAGEN     318    318       S->A: Loss of Ca(2+)-calmodulin
FT                                independent phosphorylation, increase in
FT                                apoptotic activity.
FT   MUTAGEN     318    318       S->D: Abolishes apoptotic activity.
FT   MUTAGEN     320    320       S->A: No effect on Ca(2+)-calmodulin
FT                                independent phosphorylation or apoptotic
FT                                activity.
FT   MUTAGEN     323    323       S->A: No effect on Ca(2+)-calmodulin
FT                                independent phosphorylation or apoptotic
FT                                activity.
FT   MUTAGEN     329    329       T->A: No effect on Ca(2+)-calmodulin
FT                                independent phosphorylation or apoptotic
FT                                activity.
FT   CONFLICT    241    241       A -> S (in Ref. 2; AAC35001).
FT   CONFLICT    253    253       Q -> H (in Ref. 2; AAC35001).
FT   HELIX        19     22
FT   STRAND       23     31
FT   STRAND       33     42
FT   TURN         43     45
FT   STRAND       48     56
FT   STRAND       58     61
FT   STRAND       63     66
FT   HELIX        68     80
FT   STRAND       89     94
FT   STRAND       96    103
FT   HELIX       111    116
FT   HELIX       123    142
FT   HELIX       152    154
FT   STRAND      155    158
FT   STRAND      162    164
FT   STRAND      167    169
FT   HELIX       191    193
FT   HELIX       196    199
FT   HELIX       207    222
FT   HELIX       232    240
FT   HELIX       248    251
FT   HELIX       256    263
FT   TURN        270    272
FT   HELIX       276    281
FT   TURN        283    285
FT   HELIX       290    298
FT   HELIX       303    312
FT   TURN        320    324
SQ   SEQUENCE   370 AA;  42898 MW;  035E914BBCD881A2 CRC64;
     MFQASMRSPN MEPFKQQKVE DFYDIGEELG SGQFAIVKKC REKSTGLEYA AKFIKKRQSR
     ASRRGVSREE IEREVSILRQ VLHHNVITLH DVYENRTDVV LILELVSGGE LFDFLAQKES
     LSEEEATSFI KQILDGVNYL HTKKIAHFDL KPENIMLLDK NIPIPHIKLI DFGLAHEIED
     GVEFKNIFGT PEFVAPEIVN YEPLGLEADM WSIGVITYIL LSGASPFLGD TKQETLANIT
     AVSYDFDEEF FSQTSELAKD FIRKLLVKET RKRLTIQEAL RHPWITPVDN QQAMVRRESV
     VNLENFRKQY VRRRWKLSFS IVSLCNHLTR SLMKKVHLRP DEDLRNCESD TEEDIARRKA
     LHPRRRSSTS
//
